Boff, I can't believe you too are now lumping us in the pre p1a basket
We don't know the 'go to market' strategy. Eg. AML is ready for rapid expansion, IND slated for 2025, etc. Hope to hear more in the upcoming presentations.
Sitting on your hands hoping the piggyback options are executed is not a viable strategy given the current geopolitical climate - and I don't think they're doing this. Volume still anaemic here. The company needs to start incentivising new investment, today. A large portion of these tails will be covered by heads...
Look at the explosion in volume at DXB post their first licensing deal in late 2023, which is currently being held back by well in the money options (RAC might have this problem through to May 2026)...
(20min delay)